Literature DB >> 14186654

BRACHYDACTYLY, PECULIAR FACIES AND MENTAL RETARDATION.

G S COFFIN.   

Abstract

Keywords:  ABNORMALITIES; BRAIN DISEASES; CHILD; DEGLUTITION DISORDERS; ENDOCARDIAL FIBROELASTOSIS; ENTERITIS; FACIAL EXPRESSION; FINGERS; GENETICS, HUMAN; HAND DEFORMITIES; INFANT; MENTAL RETARDATION; MUSCULAR DISEASES; PATHOLOGY; TOES

Mesh：

Year:  1964        PMID： 14186654     DOI： 10.1001/archpedi.1964.02090010353004

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  7 in total

1.  Rubinstein-Taybi's syndrome.

Authors:  B R Santhanakrishnan
Journal:  Indian J Pediatr       Date:  1971-06       Impact factor: 1.967

2.  The Rubinstein-Taybi syndrome.

Authors:  C J Padfield; M W Partington; N E Simpson
Journal:  Arch Dis Child       Date:  1968-02       Impact factor: 3.791

3.  The Rubinstein-Taybi syndrome: a report of two cases.

Authors:  M A Salmon
Journal:  Arch Dis Child       Date:  1968-02       Impact factor: 3.791

Review 4.  Rubinstein-Taybi syndrome.

Authors:  A C Berry
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

5.  Rubinstein-Taybi syndrome: report of a case in a Nigerian child.

Authors:  E O Okoroma; G I Izuora
Journal:  J Natl Med Assoc       Date:  1987-11       Impact factor: 1.798

Review 6.  Surgical treatment of scoliosis in Rubinstein-Taybi syndrome type 2: a case report.

Authors:  Nikolaos Bounakis; Christos Karampalis; Hilary Sharp; Athanasios I Tsirikos
Journal:  J Med Case Rep       Date:  2015-01-18

7.  The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.

Authors:  Melanie Schoof; Michael Launspach; Dörthe Holdhof; Lynhda Nguyen; Verena Engel; Severin Filser; Finn Peters; Jana Immenschuh; Malte Hellwig; Judith Niesen; Volker Mall; Birgit Ertl-Wagner; Christian Hagel; Michael Spohn; Beat Lutz; Jan Sedlacik; Daniela Indenbirken; Daniel J Merk; Ulrich Schüller
Journal:  Acta Neuropathol Commun       Date:  2019-12-05       Impact factor: 7.801
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.